AKBA
Akebia Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.46
+0.06 ▲ +4.29%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$1.48
+0.02 ▲ +1.37%
| Index | RUT | P/E | - | EPS (ttm) | -0.02 | Insider Own | 3.5% | Shs Outstand | 0.27B | Perf Week | 14.96% |
| Market Cap | 0.39B | Forward P/E | - | EPS next Y | -132.26% | Insider Trans | -5.81% | Shs Float | 0.26B | Perf Month | -5.81% |
| Enterprise Value | 0.42B | PEG | - | EPS next Q | -0.03 | Inst Own | 46.01% | Short Float | 11.49% | Perf Quarter | -10.43% |
| Income | -0.01B | P/S | 1.66 | EPS this Y | -210% | Inst Trans | -2.05% | Short Ratio | 9.23 | Perf Half Y | -51.17% |
| Sales | 0.24B | P/B | 11.88 | EPS next 5Y | - | ROA | -1.79% | Short Interest | 29.69M | Perf YTD | -9.32% |
| Book/sh | 0.12 | P/C | 2.1 | EPS past 3/5Y | 65.7% 62.4% | ROE | - | 52W High | -64.2% ($4.08) | Perf Year | -13.61% |
| Cash/sh | 0.7 | P/FCF | 5.78 | Sales past 3/5Y | -6.88% -4.37% | ROIC | -2.56% | 52W Low | 28.07% ($1.14) | Perf 3Y | 93.3% |
| Dividend Est. | - | EV/EBITDA | 16.99 | EPS Y/Y TTM | 94.76% | Gross Margin | 82.76% | Volatility(W/M) | 6.61% 7.57% | Perf 5Y | -59.56% |
| Dividend TTM | - | EV/Sales | 1.78 | Sales Y/Y TTM | 47.46% | Oper. Margin | 9.95% | ATR (14) | 0.09 | Perf 10Y | -83.14% |
| Dividend Ex-Date | - | Quick Ratio | 1.46 | EPS Q/Q | 55.8% | Profit Margin | -2.26% | RSI (14) | 60.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.55 | Sales Q/Q | 23.93% | SMA20 | 14.87% ($1.27) | Beta | 0.38 | Target Price | $4.4 |
| Payout | - | Debt/Eq | 6.63 | Earnings | 2000000 | SMA50 | 6.46% ($1.37) | Rel Volume | 1.17 | Prev Close | $1.4 |
| Employees | 194 | LT Debt/Eq | 5.4 | EPS/Sales Surpr. | -38.89% 25.01% | SMA200 | -41.08% ($2.48) | Avg Volume(3M) | 3.22M | Price | $1.46 |
| IPO | 2014/3/20 | Option/Short | Yes/Yes | Trades | 7240 | Volume | 3,751,038 | Change | 4.29% |
뉴스 로딩 중...